Breakthrough Genomic Test Could Spare Millions of Breast Cancer Patients from Chemotherapy
A groundbreaking genomic testing technology could help millions of breast cancer patients avoid unnecessary chemotherapy.
A groundbreaking genomic testing technology could help millions of breast cancer patients avoid unnecessary chemotherapy.
A clinical trial at São Paulo State University in Brazil found that a daily supplement of 2,000 IU vitamin D increased the rate of complete tumor disappearance after chemotherapy from 24% to 43%, suggesting an affordable intervention that warrants further investigation.